HighLife, a France-based maker of mitral valve replacement technology, announced today that it appointed Stefan Pilz as its new CEO. Paris-based HighLife develops a novel trans-septal mitral valve replacement (TMVR) for treating mitral regurgitation (MR). Pilz’s move into the outfit’s corner office goes into effect on Aug. 1, 2024. He succeeds founder and CEO Georg […]
HighLife
HighLife unveils new large annular valve for mitral regurgitation clinical trials
HighLife SAS announced today that it introduced a new valve size in its clinical trials for treating mitral regurgitation (MR) in larger anatomies. Paris-based HighLife’s latest trans-septal mitral valve replacement (TSMVR) is a large annulus valve (LAV). The company designed it to fit within its existing delivery catheter and to accommodate large annuli up to […]
HighLife raises $36m Series B for mitral valve replacement
HighLife said today that it raised a Series B round worth more than $36 million for the transcatheter mitral valve replacement it’s developing. HighLife’s TMVR uses a ring around the diseased valve’s leaflets that’s designed to guide the replacement valve into position. It’s designed to be delivered through the inter-atrial septum, rather than via a trans-apical […]
8 companies commercializing transcatheter mitral valve replacements
Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used […]
HighLife Medical raises $14m for transcatheter mitral valve replacement
HighLife Medical said today that it raised more than $14 million for the replacement heart valve it’s developing to treat mitral regurgitation. Paris- and Irvine, Calif.-based HighLife said the €12.3 million round was led by European venture capital shop Soffinova Partners, joined by prior backers LivaNova (NSDQ:LIVN) and HighLife founder & CEO Georg Börtlein – who also co-founded […]
Sorin puts some skin in mitral valve replacement company HighLife
Italian medical device maker Sorin Group (BIT:SRN) made a $5.4 million (€4.2 million) minority investment with option-to-buy in HighLife SAS, developer of transcatheter mitral valve replacement technology.
